Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-κB and AP-1 signaling pathways-Reference-Cited by-同舟云学术

Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-κB and AP-1 signaling pathways

Published:2021-05-27 Issue:1 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Hong On-Yu¹,Jang Hye-Yeon¹,Park Kwang-Hyun²,Jeong Young-Ju³,Kim Jong-Suk¹,Chae Hee³

Affiliation:

1. Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea

2. Department of Emergency Medical Rescue, Nambu University, Gwangju 62271, Republic of Korea

3. Department of Obstetrics and Gynecology, Research Institute of Clinical Medicine of Jeonbuk National University and Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk 54907, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation;International Journal of Pharmaceutics;2024-10

2. The Cytoprotective Effect of C60 Derivatives in the Self-Microemulsifying Drug Delivery System against Triptolide-Induced Cytotoxicity In Vitro;Molecules;2024-08-28

3. Engineering a pH‐responsive polymeric micelle co‐loaded with paclitaxel and triptolide for breast cancer therapy;Cell Proliferation;2024-01-16

4. Engineering a pH-responsive polymeric micelle co-loaded with paclitaxel and tretinoin for breast cancer therapy;2023-11-20

5. A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes;Biomedicine & Pharmacotherapy;2023-06